Announced
Completed
Elliminist Singapore completed the acquisition of Sagent Pharmaceuticals and Omega Laboratories from Nichi-Iko Pharmaceutical for $100m.
Financials
Transaction Value£83m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-
Sources
Tags
Completed
Pharmaceuticals
Friendly
Cross Border
Majority
pharmaceutical products
Single Bidder
Acquisition
Private
United States
Canada
Synopsis
Elliminist Singapore completed the acquisition of Sagent Pharmaceuticals and Omega Laboratories from Nichi-Iko Pharmaceutical, a generic drug manufacturer, for $100m.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.